New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
09:10 EDTSUPNSupernus announces issuance of first use patents for SPN-812
Supernus Pharmaceuticals announced the issuance of a European patent and Canadian patent for SPN-812, its novel non-stimulant product candidate for the treatment of ADHD. These patents will provide protection for the product with expiration that is no earlier than 2029. Supernus has several additional patent applications for SPN-812 pending in other geographic regions, including the United States.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 10, 2014
07:35 EDTSUPNSupernus announces Paragraph IV ANDA filing for Oxtellar XR
Subscribe for More Information
December 9, 2014
07:36 EDTSUPNSupernus announces Paragraph IV ANDA filing for Trokendi XR
Subscribe for More Information
December 8, 2014
17:24 EDTSUPNOrchard Hill lowers stake in Supernus to 4.99% from 7.0%
Stake includes convertible notes.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use